Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life

Supportive Care in Cancer

Volumn 23, Issue 9, 2015, Pages 2789-2797

  Baz, R ^a   Lin, H M ^b   Hui, A M ^b   Harvey, R D ^c   Colson, K ^d   Gallop, K ^e   Swinburn, P ^f   Laubach, J ^d   Berg, D ^b   Richardson, P ^d  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c EMORY UNIVERSITY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e ICON PLC   (United Kingdom)

^f MAPI GROUP   (Netherlands)

Author keywords

Conceptual model; Health related quality of life; Multiple myeloma

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; IXAZOMIB; LENALIDOMIDE; PROTEASOME INHIBITOR; THALIDOMIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BACKACHE; BONE INJURY; BONE PAIN; BREATHING DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSPNEA; FATIGUE; FEMALE; FRACTURE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; INSOMNIA; MALE; MEDICAL HISTORY; MULTIPLE MYELOMA; NAUSEA; NEUROPATHY; OPEN ENDED QUESTIONNAIRE; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEMI STRUCTURED INTERVIEW; SOCIAL BEHAVIOR; TELEPHONE INTERVIEW; THEMATIC ANALYSIS; UNITED STATES; MIDDLE AGED; PSYCHOLOGICAL MODEL; PSYCHOLOGY; QUESTIONNAIRE;

AGED; ANTINEOPLASTIC AGENTS; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; MULTIPLE MYELOMA; PAIN; QUALITATIVE RESEARCH; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84938419895     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2644-6     Document Type: Article

References (26)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA. Cancer J Clin 64:9–29
2. Richardson PG, Laubach J, Mitsiades CS, Schlossman R, Hideshima T, Redman K, Chauhan D, Ghobrial IM, Munshi N, Anderson KC (2011) Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settings. Br J Haematol 154:755–762
3. Cachia E, Eiser C, Ezaydi Y (2012) A study of pain, peripheral neuropathy and psychosocial late effects in multiple myeloma patients. BMJ Support Palliat Care 2:A3
4. Roodman GD (1997) Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer 80:1557–1563
5. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein MA, Coleman RE, Reitsma DJ, Chen BL, Seaman JJ (2013) Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 98:1735–1744
6. Mundy GR (1998) Myeloma bone disease. Eur J Cancer 34:246–251
7. Booker R, Olson K, Pilarski LM, Noon JP, Bahlis NJ (2009) The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma. Oncol Nurs Forum 36:209–216
8. Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28:465–470
9. Bilezikian JP (1992) Management of acute hypercalcemia. N Engl J Med 326:1196–1203
10. Smith D, Yong K (2013) Multiple myeloma. BMJ 346:f3863
11. Laubach JP, Mitsiades CS, Mahindra A, Schlossman RL, Hideshima T, Chauhan D, Carreau NA, Ghobrial IM, Raje N, Munshi NC, Anderson KC, Richardson PG (2009) Novel therapies in the treatment of multiple myeloma. J Natl Compr Cancer Netw 7:947–960
12. Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F, LeBlanc R, Catley LP, Doss D, Kelly K, McKenney M, Mechlowicz J, Freeman A, Deocampo R, Rich R, Ryoo JJ, Chauhan D, Balinski K, Zeldis J, Anderson KC (2002) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood 100:3063–3067
13. Osborne TR, Ramsenthaler C, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2012) What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. Eur J Haematol 89:437–457
14. Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89:311–319
15. Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ (2009) Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 15:12–20
16. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B (2007) Patient-reported outcomes: conceptual issues. Value Health 10:S66–S75
17. Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101
18. ATLAS.ti Qualitative Data Analysis Software (Version 5) (Software) (2014) Retrieved from http://atlasti.com/
19. Morse JM (1995) The significance of saturation. Qual Health Res 5:147–149
20. Maher K, deVries K (2011) An exploration of the lived experiences of individuals with relapsed multiple myeloma. Eur J Cancer Care (Engl) 20:267–275
21. Potrata B, Cavet J, Blair S, Howe T, Molassiotis A (2011) Understanding distress and distressing experiences in patients living with multiple myeloma: an exploratory study. Psychooncology 20:127–134
22. Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology 20:88–97
23. Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Living with multiple myeloma: experiences of patients and their informal caregivers. Support. Care Cancer 19:101–111
24. U.S.Cancer StatisticsWorking Group. United States Cancer Statistics: 1999–2010 Incidence and Mortality Web-based Report. Atlanta: U.S. (2013) Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Available at http://www.cdc.gov/uscs
25. Sturges JE, Hanrahan KJ (2004) Comparing telephone and face-to-face qualitative interviewing: a research note. Qual Res 4(1):107–118
26. Irvine A (2011) Duration, dominance and depth in telephone and face-to-face interviews: a comparative exploration. Int J Qualitative Methods 10(3):202–220